Quality Incident & CAPA Management

Integrate the Quality Management Systems operations across the global enterprise, fostering compliance with GxP

Even with robust Quality Management Systems (QMS) in place, pharmaceutical and biotech companies can still face unforeseen risks that reduce the effectiveness and compliance of their systems. This is particularly true when trying to control changes across multiple sites in a global enterprise and answering to auditors and inspectors in a consistent manner.

Designed for the highly regulated life sciences environment, Quality Incident & CAPA Management provides end-to-end document and Quality process management. Data can be captured, reviewed, processed and approved through an interface that acts as a single point of access for company compliance content.

Quality Incident & CAPA Management benefits pharma and biotech companies by integrating and enacting their Quality Management Systems across their global operations. They will be able to access QMS documents and data from anywhere, with full traceability of each of the processes addressed. With secure, audited data sharing, organizations can demonstrate adherence to quality processes and minimize recalls.  This improves yields while enhancing product quality and optimizes quality processes to mitigate risk.